Advancing Canada’s Life Sciences Industry.

Cell and Gene Therapy - Canada's Chance To Be a Global Leader in Life Sciences Canada is well on the way to becoming a global leader in the commercialization, investment, and manufacturing of cell and gene therapies. Ongoing investments within Canada In 2023, Novartis has renewed its commitment and investment within Canada with the launch of two cutting-edge new offices. "We've had strong support from the Canadian ALS community, who fiercely advocate for expedited review of, and access to, treatments for ALS", said Chris Aiello, General Manager and Head of Canada at Amylyx. Why Advancing IDEA Is Good for Canada's Life Sciences Sector To enhance Canada's life sciences sector, embedding inclusion, diversity, equity, and accessibility (IDEA) is crucial for fostering innovation and attracting talent. [Extracted from the article]